In The News

Hospital CFO Report

46 RCM tips from 2018

Tip #9: Parag Shah, president of practice solutions at Integra Connect, a provider of technologies and services for value-based specialty care, advised specialty medical practices to focus on performance optimization and risk management to ensure their revenue cycles meet new value-based care requirements.

Read more

the center for biosimilars

Charles Saunders, MD: Biosimilars in Specialty Pharmacy

How are you seeing biosimilars impact the world of specialty pharmacy? I think that the promise of biosimilars to bring down the cost of drugs is certainly out there based on the experience that we’ve had with generics. I’m not sure that we’re really seeing the impact as great, though, because the prices of the biosimilars are not that much lower than the other drugs–so, maybe 25% to 35% reduction.

Read more

Hospital CFO Report

6 recent RCM tips

Here are six expert revenue cycle management tips, published by Becker’s Hospital Review after Nov. 21. … 5. Parag Shah, president of practice solutions at Integra Connect, a provider of technologies and services for value-based specialty careadvised specialty medical practices to focus on performance optimization and risk management to ensure their revenue cycles meet new value-based care requirements.

Read more

AJMC - Managed Markets Network

Common Factors Among Successful Practices in the OCM

Practices participating in the Oncology Care Model have now received performance results for 2 periods, and many practices were surprised that they didn’t perform as well as expected. In general, some of the practices have found it difficult to predict success in the model, but there have been positive results from the OCM.

Read more

Becker's hospital review

RCM tip of the day: Align revenue cycle with new value-based care requirements

Specialty medical practices should focus on performance optimization and risk management to ensure their revenue cycles meet new value-based care requirements, advised Parag Shah, president of practice solutions at Integra Connect, a provider of technologies and services for value-based specialty care.

Read more

The Oncology Care Model Performance Period 2 Results: Practices Are Making Some Progress, But Major Challenges Remain

When launched in 2016, the Oncology Care Model (OCM) represented one of the most advanced efforts yet to migrate health care delivery from fee-for-service to fee-for-value. Practices representing nearly 3000 oncologists signed on to participate. Since then, much has been written about potential strengths and weaknesses of the model. New to the discussion is a wave of data. Practices received the results of their first performance period in February 2018 and the second performance period at the end of August 2018. This has afforded them the opportunity to identify strengths and areas for improvement, both based on what the data tells them and how it changes across performance periods. This article draws on the aggregated data and experiences of a large segment of community OCM participants to highlight the primary challenges that arose once practices were confronted with the Centers for Medicare & Medicaid Service’s assessment of their performance. In addition, the article highlights high-impact interventions that oncology practices are undertaking to further improve both care quality and cost.

Read more

Hospital CFO Report

RCM tip of the day: Align revenue cycle with new value-based care requirements

Specialty medical practices should focus on performance optimization and risk management to ensure their revenue cycles meet new value-based care requirements, advised Parag Shah, president of practice solutions at Integra Connect, a provider of technologies and services for value-based specialty care. He recommended practices first focus on optimizing their performance based on value instead of collections based on the number of patients seen.

Read more

AJMC - Managed Markets Network

Delay in Performance Period Results Challenges Practices Participating in OCM

Practices participating in the Oncology Care Model (OCM) recently received the results from performance period 2, but they’re currently enrolling patients for performance period 5. This lag time between the end of a performance period and the release of the full report represents a challenge for practices looking to improve.

Read more

health data management - The Resource for Healthcare IT Leaders

Two urology practices select Integra Connect to replace EHRs

The Urology Group, with 15 sites serving parts of Ohio and Kentucky, and the Michigan Institute Urology, with 22 sites in southeast Michigan, both are replacing legacy electronic health record systems and selecting the same vendor—Integra Connect. Some 39 physicians at The Urology Group recently went live on the EHR as the organization prepares for the shift to value-based care. “We have long seen the need for a new wave of innovation among urology EHRs to better equip practices like ours for the changes in our specialty in general and with the shift to value-based care in particular,” says Gary Kirsh, MD, the group’s president.

Read more

managed healthcare executive

Three Keys to Success in the Oncology Care Model

Oncology providers did better in the second performance period of CMS’ Oncology Care Model (OCM) than they did in the first one, but there’s certainly room for further improvement. That’s according to Charles Saunders, MD, CEO of West Palm Beach, Florida-based Integra Connect, which develops IT solutions for healthcare providers. The company works with approximately 1,000 oncologists who treat close to 300,000 patients in the OCM program.

Read more